Kanao K, Takahashi T, Umezawa Y, Okabe T, et al. Efficacy of abiraterone acetate for high-risk hormone-naive metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone. PLoS One 2022;17:e0276081.
PMID: 36264927